2023 - Research.com Immunology in United Kingdom Leader Award
2017 - Fellow of the Royal Society of Edinburgh
2012 - Member of Academia Europaea
2011 - Fellow of the Royal Society, United Kingdom
Member of the Association of American Physicians
Fellow of The Academy of Medical Sciences, United Kingdom
The scientist’s investigation covers issues in Immunology, Complement system, Lupus erythematosus, Internal medicine and Immune system. The study incorporates disciplines such as Systemic lupus erythematosus and Glomerulonephritis in addition to Immunology. His work in Complement system addresses issues such as Molecular biology, which are connected to fields such as Amyloid, Pentraxins, CD59, Hemoglobinuria and Hemolysis.
His research in Lupus erythematosus tackles topics such as Pathology which are related to areas like Leukotriene B4, Erythema, Prostaglandin E2 and Cardiology. Mark Walport combines subjects such as Gastroenterology and Endocrinology with his study of Internal medicine. His Immune system research is multidisciplinary, relying on both Receptor, Pathogenesis and In vivo.
Mark Walport mainly investigates Immunology, Lupus erythematosus, Immune system, Molecular biology and Internal medicine. His Antibody, Complement system, Autoimmune disease, Autoantibody and Autoimmunity study are his primary interests in Immunology. His Lupus erythematosus research integrates issues from Systemic disease, Immunopathology, Systemic lupus erythematosus, Connective tissue disease and Anti-SSA/Ro autoantibodies.
His Immune system study incorporates themes from Receptor and In vivo. His Molecular biology study integrates concerns from other disciplines, such as Genetics, Gene and Exon. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology.
Mark Walport mainly focuses on Immunology, Complement system, Autoimmunity, Immune system and Glomerulonephritis. His study in Autoantibody, Nephritis, Antibody, Lupus erythematosus and Autoimmune disease falls under the purview of Immunology. Mark Walport works mostly in the field of Lupus erythematosus, limiting it down to topics relating to Systemic lupus erythematosus and, in certain cases, In vivo, as a part of the same area of interest.
Mark Walport has included themes like Apoptosis and Complement deficiency in his Autoimmunity study. His biological study deals with issues like Cell biology, which deal with fields such as Complement factor B. His Glomerulonephritis study which covers Bone marrow that intersects with Transplantation.
His primary areas of study are Immunology, Complement system, Classical complement pathway, Autoimmunity and Immune system. The various areas that Mark Walport examines in his Immunology study include Systemic lupus erythematosus, Glomerulonephritis and Haplotype. Mark Walport usually deals with Complement system and limits it to topics linked to Molecular biology and Bone marrow, Phagocytosis, In vitro, Complement factor B and Isotype.
His Classical complement pathway research is multidisciplinary, relying on both Complement and Complement receptor. Mark Walport has researched Autoimmunity in several fields, including Phenotype, Gene, C57BL/6, Lupus erythematosus and In vivo. His research investigates the connection between Immune system and topics such as Apoptosis that intersect with problems in Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Complement. First of two parts.
Mark J. Walport.
The New England Journal of Medicine (2001)
Grand challenges in global mental health
Pamela Y. Collins;Vikram Patel;Vikram Patel;Sarah S. Joestl;Dana March;Dana March.
(2011)
Complement. Second of two parts.
Mark J. Walport.
The New England Journal of Medicine (2001)
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.
John S Savill;Andrew H. Wyllie;Janet E Henson;Mark J Walport.
Journal of Clinical Investigation (1989)
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
M Botto;C Dell'Agnola;A E Bygrave;E M Thompson.
Nature Genetics (1998)
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.
Philip R. Taylor;Anna Carugati;Valerie A. Fadok;H. Terence Cook.
Journal of Experimental Medicine (2000)
Arthritis Critically Dependent on Innate Immune System Players
Hong Ji;Koichiro Ohmura;Koichiro Ohmura;Umar Mahmood;David M Lee.
Immunity (2002)
The Role of Complement in the Development of Systemic Lupus Erythematosus
Anthony P Manderson;Marina Botto;Mark J Walport.
Annual Review of Immunology (2004)
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity.
M.C.M. Bickerstaff;M. Botto;W.L. Hutchinson;J. Herbert.
Nature Medicine (1999)
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
A H Fielder;M J Walport;J R Batchelor;R I Rynes.
BMJ (1983)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Yale University
Imperial College London
Cardiff University
Imperial College London
Imperial College London
King's College London
London Bridge Hospital
University College London
Imperial College London
Cardiff University
Chuo University
University College Dublin
University of Jinan
Xi'an Jiaotong University
University of Groningen
China University of Geosciences
The Ohio State University
University of Kentucky
University of British Columbia
University of California, San Diego
Salk Institute for Biological Studies
University of California, Los Angeles
International Agency For Research On Cancer
School for Advanced Studies in the Social Sciences
University of Minnesota
Goethe University Frankfurt